Larson Financial Group’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72 | Hold |
22
| – | – | ﹤0.01% | 3175 |
|
|
2025
Q1 | $45 | Hold |
22
| – | – | ﹤0.01% | 2975 |
|
|
2024
Q4 | $48 | Hold |
22
| – | – | ﹤0.01% | 2694 |
|
|
2024
Q3 | $37 | Hold |
22
| – | – | ﹤0.01% | 2636 |
|
|
2024
Q2 | $54 | Hold |
22
| – | – | ﹤0.01% | 2349 |
|
|
2024
Q1 | $103 | Hold |
22
| – | – | ﹤0.01% | 1698 |
|
|
2023
Q4 | $100 | Hold |
22
| – | – | ﹤0.01% | 1709 |
|
|
2023
Q3 | $57 | Hold |
22
| – | – | ﹤0.01% | 1674 |
|
|
2023
Q2 | $105 | Hold |
22
| – | – | ﹤0.01% | 1517 |
|
|
2023
Q1 | $144 | Hold |
22
| – | – | ﹤0.01% | 1480 |
|
|
2022
Q4 | $242 | Hold |
22
| – | – | ﹤0.01% | 1414 |
|
|
2022
Q3 | $0 | Hold |
22
| – | – | ﹤0.01% | 1368 |
|
|
2022
Q2 | $0 | Hold |
22
| – | – | ﹤0.01% | 1258 |
|
|
2022
Q1 | $1K | Hold |
22
| – | – | ﹤0.01% | 977 |
|
|
2021
Q4 | $1K | Hold |
22
| – | – | ﹤0.01% | 1022 |
|
|
2021
Q3 | $2K | Buy |
+22
| New | +$2K | ﹤0.01% | 788 |
|